185 related articles for article (PubMed ID: 1846110)
1. Tamoxifen inhibition of prolactin action in the mouse mammary gland.
Biswas R; Vonderhaar BK
Endocrinology; 1991 Jan; 128(1):532-8. PubMed ID: 1846110
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line.
Biswas R; Vonderhaar BK
Cancer Res; 1989 Nov; 49(22):6295-9. PubMed ID: 2804977
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of a membrane-associated antilactogen binding site for tamoxifen.
Das RB; Biswas R; Vonderhaar BK
Mol Cell Endocrinol; 1993 Dec; 98(1):1-8. PubMed ID: 8143909
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by estradiol of the lactogenic effect of prolactin in primate mammary tissue: reversal by antiestrogens LY 156758 and tamoxifen.
Kleinberg DL; Todd J; Babitsky G
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4144-8. PubMed ID: 6575400
[TBL] [Abstract][Full Text] [Related]
6. Prolactin mediation of estrogen-induced changes in mammary tissue estrogen and progesterone receptors.
Muldoon TG
Endocrinology; 1987 Jul; 121(1):141-9. PubMed ID: 3595517
[TBL] [Abstract][Full Text] [Related]
7. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
Watts CK; Sutherland RL
Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
[TBL] [Abstract][Full Text] [Related]
8. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
9. Prolactin induces release of a factor from membranes capable of stimulating beta-casein gene transcription in isolated mammary cell nuclei.
Teyssot B; Houdebine LM; Djiane J
Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6729-33. PubMed ID: 7031659
[TBL] [Abstract][Full Text] [Related]
10. Short-term regulation of prolactin receptors in the liver, mammary gland and kidney of pregnant and lactating rats infused with ovine prolactin or human growth hormone.
Barash I; Madar Z; Gertler A
Mol Cell Endocrinol; 1986 Aug; 46(3):235-44. PubMed ID: 3017782
[TBL] [Abstract][Full Text] [Related]
11. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
12. Distribution of antiestrogen-specific binding sites in normal and neoplastic mammary gland.
Mehta RG; Cerny WL; Moon RC
Oncology; 1984; 41(6):387-92. PubMed ID: 6504492
[TBL] [Abstract][Full Text] [Related]
13. Evolution of prolactin and placental lactogen receptors in ewes during pregnancy and lactation.
Emane MN; Delouis C; Kelly PA; Djiane J
Endocrinology; 1986 Feb; 118(2):695-700. PubMed ID: 3002762
[TBL] [Abstract][Full Text] [Related]
14. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical and genetic evidence for specific antiestrogen binding sites.
Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
[TBL] [Abstract][Full Text] [Related]
16. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus.
Lyman SD; Jordan VC
Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716
[TBL] [Abstract][Full Text] [Related]
17. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens.
Silberstein GB; Van Horn K; Shyamala G; Daniel CW
Endocrinology; 1994 Jan; 134(1):84-90. PubMed ID: 8275973
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogen binding sites in brain and pituitary of ovariectomized rats.
Gray JM; Ziemian L
Brain Res; 1992 Apr; 578(1-2):55-60. PubMed ID: 1511289
[TBL] [Abstract][Full Text] [Related]
19. Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis.
Cypriani B; Tabacik C; Descomps B; Crastes de Paulet A
J Steroid Biochem; 1988 Nov; 31(5):763-71. PubMed ID: 3199816
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen inhibits prolactin signal transduction in ER - NOG-8 mammary epithelial cells.
Das R; Vonderhaar BK
Cancer Lett; 1997 Jun; 116(1):41-6. PubMed ID: 9177456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
